Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
HURT (Headache Under-Response to Treatment) questionnaire in the management of primary headache disorders: reliability, validity and clinical utility of the Arabic version.
J Headache Pain. 2013 Feb 21;14(1):16. doi: 10.1186/1129-2377-14-16.
J Headache Pain. 2013.
PMID: 23565801
Free PMC article.
Familial multiple sclerosis: does consanguinity have a role?
Al Jumah M, Kojan S, Al Khathaami A, Al Abdulkaream I, Al Blawi M, Jawhary A.
Al Jumah M, et al. Among authors: jawhary a.
Mult Scler. 2011 Apr;17(4):487-9. doi: 10.1177/1352458510390406. Epub 2010 Dec 21.
Mult Scler. 2011.
PMID: 21177327
Item in Clipboard
A Prospective Multicenter Study for Assessing MusiQoL Validity among Arabic-Speaking MS Patients Treated with Subcutaneous Interferon β-1a.
Al Jumah M, Kojan S, Alroughani R, Cupler E, Bohlega S, Daif A, Al Mujalli M, Al Harbi T, El Tamawy M, Ashour S, Mhiri C, Gouider R, Jawhary A, El Boghdady A, Hussein M.
Al Jumah M, et al. Among authors: jawhary a.
Mult Scler Int. 2021 Mar 2;2021:6681431. doi: 10.1155/2021/6681431. eCollection 2021.
Mult Scler Int. 2021.
PMID: 33747564
Free PMC article.
Item in Clipboard
Association of SNPs rs6498169 and rs10984447 with multiple sclerosis in Saudi patients: a model of the usefulness of familial aggregates in identifying genetic linkage in a multifactorial disease.
Al Jumah M, Al Balwi M, Hussein M, Kojan S, Al Khathaami A, Al Fawaz M, Al Muzaini B, Jawhary A, Al Abdulkareem I.
Al Jumah M, et al. Among authors: jawhary a.
Mult Scler. 2012 Oct;18(10):1395-400. doi: 10.1177/1352458512440832. Epub 2012 Apr 4.
Mult Scler. 2012.
PMID: 22492128
Item in Clipboard
Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial.
Bosaeed M, Balkhy HH, Almaziad S, Aljami HA, Alhatmi H, Alanazi H, Alahmadi M, Jawhary A, Alenazi MW, Almasoud A, Alanazi R, Bittaye M, Aboagye J, Albaalharith N, Batawi S, Folegatti P, Ramos Lopez F, Ewer K, Almoaikel K, Aljeraisy M, Alothman A, Gilbert SC, Khalaf Alharbi N.
Bosaeed M, et al. Among authors: jawhary a.
Lancet Microbe. 2022 Jan;3(1):e11-e20. doi: 10.1016/S2666-5247(21)00193-2. Epub 2021 Nov 3.
Lancet Microbe. 2022.
PMID: 34751259
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite